<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00793611</url>
  </required_header>
  <id_info>
    <org_study_id>08-102</org_study_id>
    <nct_id>NCT00793611</nct_id>
  </id_info>
  <brief_title>Hypnotherapy for Treatment of Overactive Bladder</brief_title>
  <official_title>Hypnotherapy for Treatment of Overactive Bladder: A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators purpose is to perform a pilot study evaluating the efficacy in hypnotherapy
      in treating women with Overactive Bladder Symptoms (urinary urgency symptoms and urinary
      frequency). Approximately half the women in the study will receive &quot;standard care&quot;
      (performing a voiding diary, Pelvic Floor exercises, and timed voiding) and the other half
      will receive &quot;standard care&quot; and 3 hypnotherapy sessions. The investigators will compare the
      groups using a validated overactive bladder questionnaire and compare voiding diaries to
      evaluate urinary frequency at the end of the sessions/study completion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Experimental Design and Methods:

      i) This is a feasibility study (prior to performing a larger randomized controlled trial at a
      later date) evaluating whether hypnotherapy effectively treats Overactive Bladder (OAB).
      Ultimately, for the larger study, in order to find a 20% difference between the hypnotherapy
      group and controls, we will need to evaluate a total of approximately 66-70 women to find a
      20% difference between groups, assuming 80% power and P=0.05. However, the purpose of this
      pilot study is to evaluate the feasibility of the larger study and determine the appropriate
      control intervention and outcomes. We plan to evaluate approximately ten subjects
      (approximately twenty overall) in both the control and hypnotherapy groups.

      ii) Patients OAB will be offered entry into the study. a) Inclusion criteria: women
      experiencing 8 voids/day and an OAB Awareness tool score greater than 8. b) Exclusion
      criteria: males (since we do not care for males in the gynecology clinic), non-English
      speakers, pregnant women, women younger than 18 years old, incarcerated women, women with a
      history of bipolar disorder or schizophrenia, women unwilling to undergo hypnotherapy iii)
      Informed consent will be obtained. iv) Prior to receiving interventions, patients will be
      administered the OAB-q &amp; instructed to keep a 3 day voiding diary. If the patient has not had
      a pelvic exam in the urogynecology clinic within the last year, a pelvic exam will be
      performed.

      v) The usual standard treatments for OAB include pelvic floor exercise, voiding diaries,
      bladder drills (increasing time between voids), and anti-cholinergic medications. The control
      group will be offered any or all of our standard treatments, including Behavioral treatment
      (review of voiding diaries and instruction regarding behavioral changes). Both groups will be
      allowed to continue current OAB medications but asked not to start new medications. The
      hypnotherapy group will also be offered any or all of our standard treatments, but they will
      be given the option of receiving hypnotherapy in addition to the usual treatments.

      vi) Hypnotherapy sessions: Dr. Sapien will conduct 3 hypnotherapy session to women randomized
      to the hypnotherapy group. These sessions will occur approximately every1-2 weeks over
      approximately a time span of 6-8 weeks. The sessions will last 60-90 minutes. Session #1)
      Explain hypnotherapy and practice suggestion therapy; Session #2) address emotions around OAB
      and life impact, visualization of pelvic floor exercise mechanics, teach self hypnosis;
      Session #3) address emotions, further practice on exercises and self-hypnosis vii) Blinding
      of Investigators and Allocation Concealment: Randomization will be performed by the CTSC
      using computer generated allocation. Only the CTSC personnel will know the assignment schema.
      Researchers will not know the group assignments. A research nurse otherwise uninvolved in the
      study will place the group assignments in serially numbered, opaque envelopes. Once subjects
      sign consents they will receive an opaque envelop assigning them to the Behavioral Therapy or
      Hypnotherapy group. The individual responsible for data collection and data entry will not
      know the group assignment until the end of the study when the assignment code is broken.

      VI. Human Subjects:

      i) See inclusion &amp; exclusion criteria described previously. Children, prisoners and mentally
      ill or disabled subjects will be excluded from our study. Women who are pre-menopausal and
      who are not using contraception and have missed a menstrual period will be offered a
      pregnancy test in the clinic, as is the standard of care in the gynecology clinic. Pregnancy
      is an exclusion criteria for study participation.Women evaluated in the Gynecology Clinic at
      the University of New Mexico will be offered participation in the study.

      ii) Women will be offered study participation in a private setting at their gynecology visit
      if have the symptoms of OAB noted previously (V.ii).The study will be described verbally and
      they will receive a copy of the consent form to read. They will be given the option of taking
      the consent home to have time to consider whether they would like to participate. If the
      patient wishes more time to consider whether she would like to participate, she will be asked
      whether she would agree to phone follow-up by a study investigator. If she agrees, she will
      have phone follow-up at least 24 hours after her clinic visit. If the patient expresses
      interest in participating in the study, she will then return to sign her consent with a study
      investigator. All patients will be reassured that declining study participation will have no
      effect on the care that they receive iii) Potential Risks of Hypnotherapy: Potential Risks of
      Hypnotherapy: Risks of hypnotherapy are minimal. Hypnosis is a natural state of mind in which
      the subconscious is accessed and utilized to make a positive impact. Although, in the 1980
      false memory syndrome was described with the use of hypnotherapy in child abuse survivors,
      the current practice of hypnotherapy uses a much different approach to this therapeutic
      application. Current practice includes open-ended lines of questioning as opposed to
      suggestive or leading lines of questioning utilized with these victims.

      Risks will be minimized by using open-ended lines of questioning for all hypnotherapy
      sessions (see above). For this study the hypnotherapist is also a physician, therefore
      physician-patient confidentiality guidelines are in place. Subjects will be asked to contact
      the PI if they believe that they are suffering from a psychological burden which has occurred
      from their involvement in the study.

      It is highly unlikely that this study would be terminated, as the risks to participants are
      minimal. However, in the unlikely circumstance that a large number of hypnotherapy subjects
      complain of severe psychologic or physical discomfort with their hypnotherapy sessions
      (despite incorporation of relaxation techniques in the sessions), the study would be
      terminated. Subject case discussion will be conducted by the research team in a private
      setting

      Potential Risks to Control Group: The control group will be offered standard care for
      treatment of OAB and will not be exposed to any greater risk than usual for OAB treatments
      iv) Potential Benefits of Hypnotherapy: Alleviating or diminishing symptoms of frequent
      urinary, urinary urgency and urine leakage.

      v)Safety Oversite: The investigators will meet approximately monthly to review study progress
      and subject issues/complaints. The subjects will have follow-up with either phone or
      in-person contact with the hypnotherapist or CTSC personnel. If major events, though
      unlikely, occur, they will be reviewed with appropriate CTSC and HRRC personnel.

      vi) After the study is finished, the patients in the control group have the option of
      undergoing an approx. 20 minute relaxation hypnotherapy session with Dr. Sapien.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Overactive Bladder Symptoms (Based on OABqSF)</measure>
    <time_frame>baseline and approximately 6-12 weeks after study initiation</time_frame>
    <description>Scale information; Score ranges for oab-qsf quality of life scores range from 13-78; 13=poor quality of life 78=good quality of life. We reported change scores, with larger negative numbers indicating greater improvement in quality of life scores.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Voiding Frequency Based on Voiding Diary</measure>
    <time_frame>baseline and 6-12 weeks after study initiation</time_frame>
    <description>change in mean number of voids per 24 hours. Each participant recorded voiding frequency every 24 hours for 3 days at baseline and follow-up. A mean number of voids for every patient over 24 hours was calculated at baseline and follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Improvement</measure>
    <time_frame>6-12 weeks after study initiation (@ completion of intervention)</time_frame>
    <description>Outcome measure is only administered at follow-up and used following treatment in patients with urinary incontinence. Measure varies from 1 to 7 on a Likert scale. 1=very much better and 7=very much worse and 4=no change. Thus, lower numbers represent greater improvement.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Overactive Bladder</condition>
  <arm_group>
    <arm_group_label>Behavioral therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>&quot;Behavioral Therapy standard of care (which consists of bladder drills, voiding diaries, timed voiding and pelvic floor exercises)&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hypnotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will receive 3 hypnotherapy sessions in addition to usual behavioral treatments for overactive bladder</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral therapy standard of care</intervention_name>
    <description>controls will receive usual interventions for overactive bladder: voiding diary, bladder drills, pelvic floor exercises</description>
    <arm_group_label>Behavioral therapy</arm_group_label>
    <arm_group_label>hypnotherapy</arm_group_label>
    <other_name>behavioral treatment</other_name>
    <other_name>pelvic floor exercise</other_name>
    <other_name>bladder drills</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hypnotherapy</intervention_name>
    <description>Patients will receive 3 hypnotherapy sessions in addition to usual behavioral treatment of overactive bladder</description>
    <arm_group_label>hypnotherapy</arm_group_label>
    <other_name>hypnosis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  More than 8 voids/day

          -  Score &gt; 8 on OABq questionnaire

          -  English speaking

        Exclusion Criteria:

          -  Pregnancy

          -  Less than 18 years old

          -  History of Schizophrenia or Bipolar Disorder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuko M Komesu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico Health Sciences Center</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <results_reference>
    <citation>Freeman RM, Baxby K. Hypnotherapy for incontinence caused by the unstable detrusor. Br Med J (Clin Res Ed). 1982 Jun 19;284(6332):1831-4.</citation>
    <PMID>6805716</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2008</study_first_submitted>
  <study_first_submitted_qc>November 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2008</study_first_posted>
  <results_first_submitted>August 16, 2011</results_first_submitted>
  <results_first_submitted_qc>September 20, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 28, 2011</results_first_posted>
  <last_update_submitted>September 8, 2017</last_update_submitted>
  <last_update_submitted_qc>September 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of New Mexico</investigator_affiliation>
    <investigator_full_name>Yuko Komesu</investigator_full_name>
    <investigator_title>Assistant Professor Ob-Gyn University of new Mexico</investigator_title>
  </responsible_party>
  <keyword>Overactive Bladder</keyword>
  <keyword>Hypnotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients recruited from the Clinic. Study received IRB approval winter 2008 and recruitment occurred 2008-10.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Behavioral Therapy Standard Care</title>
          <description>received 3 behavioral therapy session</description>
        </group>
        <group group_id="P2">
          <title>Hypnotherapy</title>
          <description>received 3 sessions of behavioral therapy combined with hypnotherapy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Behavioral Therapy Standard Care</title>
          <description>received 3 behavioral therapy session</description>
        </group>
        <group group_id="B2">
          <title>Hypnotherapy</title>
          <description>received 3 sessions of behavioral therapy combined with hypnotherapy</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.4" spread="7.4"/>
                    <measurement group_id="B2" value="51.1" spread="14"/>
                    <measurement group_id="B3" value="54" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Overactive Bladder Symptoms (Based on OABqSF)</title>
        <description>Scale information; Score ranges for oab-qsf quality of life scores range from 13-78; 13=poor quality of life 78=good quality of life. We reported change scores, with larger negative numbers indicating greater improvement in quality of life scores.</description>
        <time_frame>baseline and approximately 6-12 weeks after study initiation</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Behavioral Therapy Standard Care</title>
            <description>received 3 behavioral therapy session</description>
          </group>
          <group group_id="O2">
            <title>Hypnotherapy</title>
            <description>received 3 sessions of behavioral therapy combined with hypnotherapy</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Overactive Bladder Symptoms (Based on OABqSF)</title>
          <description>Scale information; Score ranges for oab-qsf quality of life scores range from 13-78; 13=poor quality of life 78=good quality of life. We reported change scores, with larger negative numbers indicating greater improvement in quality of life scores.</description>
          <population>ITT</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-19" spread="24.9"/>
                    <measurement group_id="O2" value="-33.4" spread="15.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ITT between group differences in change scores compared for behavioral therapy and hypnotherapy groups. Power analysis: This is a pilot study underpowered find between group differences based on our power analysis(a 20% difference between groups would require 88 women, assuming 80% power and Î±=0.05 based on Freeman's study cited later). The purpose of this pilot study is to evaluate the feasibility of the larger study and determine the appropriate control intervention and outcomes</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.07</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>19 degrees of freedom</method_desc>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>.20</param_value>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Voiding Frequency Based on Voiding Diary</title>
        <description>change in mean number of voids per 24 hours. Each participant recorded voiding frequency every 24 hours for 3 days at baseline and follow-up. A mean number of voids for every patient over 24 hours was calculated at baseline and follow-up.</description>
        <time_frame>baseline and 6-12 weeks after study initiation</time_frame>
        <population>ITT change in mean number of voids/24 hours</population>
        <group_list>
          <group group_id="O1">
            <title>Behavioral Therapy Standard Care</title>
            <description>received 3 behavioral therapy session</description>
          </group>
          <group group_id="O2">
            <title>Hypnotherapy</title>
            <description>received 3 sessions of behavioral therapy combined with hypnotherapy</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Voiding Frequency Based on Voiding Diary</title>
          <description>change in mean number of voids per 24 hours. Each participant recorded voiding frequency every 24 hours for 3 days at baseline and follow-up. A mean number of voids for every patient over 24 hours was calculated at baseline and follow-up.</description>
          <population>ITT change in mean number of voids/24 hours</population>
          <units>number of voids per 24 hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="1.4"/>
                    <measurement group_id="O2" value="2.6" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>intent to treat.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.17</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Global Impression of Improvement</title>
        <description>Outcome measure is only administered at follow-up and used following treatment in patients with urinary incontinence. Measure varies from 1 to 7 on a Likert scale. 1=very much better and 7=very much worse and 4=no change. Thus, lower numbers represent greater improvement.</description>
        <time_frame>6-12 weeks after study initiation (@ completion of intervention)</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Behavioral Therapy Standard Care</title>
            <description>received 3 behavioral therapy session</description>
          </group>
          <group group_id="O2">
            <title>Hypnotherapy</title>
            <description>received 3 sessions of behavioral therapy combined with hypnotherapy</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Global Impression of Improvement</title>
          <description>Outcome measure is only administered at follow-up and used following treatment in patients with urinary incontinence. Measure varies from 1 to 7 on a Likert scale. 1=very much better and 7=very much worse and 4=no change. Thus, lower numbers represent greater improvement.</description>
          <population>ITT</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread=".97"/>
                    <measurement group_id="O2" value="2.15" spread=".3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>intent to treat</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.009</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Behavioral Therapy Standard Care</title>
          <description>received 3 behavioral therapy session</description>
        </group>
        <group group_id="E2">
          <title>Hypnotherapy</title>
          <description>received 3 sessions of behavioral therapy combined with hypnotherapy</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Yuko Komesu MD</name_or_title>
      <organization>University of New Mexico Health Sciences Center and CTSC</organization>
      <phone>505-925-4395</phone>
      <email>ykomesu@salud.unm.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

